+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Heart Failure Software Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 199 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904530
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The heart failure software market is undergoing fast-paced transformation as healthcare providers invest in advanced digital solutions to improve patient care and streamline clinical operations. Rapid regulatory evolution, changing patient needs, and a competitive technology environment are shaping investment and adoption across the sector.

Market Snapshot: Heart Failure Software Market Growth and Opportunity

The Heart Failure Software Market was valued at USD 2.47 billion in 2024 and is projected to reach USD 2.65 billion in 2025. Ongoing expansion is anticipated, with a compound annual growth rate (CAGR) of 7.36% and a forecasted market value of USD 4.37 billion by 2032. This growth is driven by rising heart failure cases and the demand to optimize care delivery and operational efficiency. Hospitals, clinics, and homecare providers are investing strategically in these technologies to support increasingly complex patient profiles and improve workflow integration.

Scope & Segmentation of the Heart Failure Software Market

  • Type: Knowledge-based platforms employ clinical guidelines for decision support, while non-knowledge-based solutions utilize advanced analytics for tailored recommendations.
  • Disease Type: Software addresses congenital, left-sided, and right-sided heart failure, each with dedicated algorithmic workflows to support distinct clinical challenges.
  • Platform: Integrated systems ensure interoperability across health networks, and standalone applications target specific clinical functions or care environments.
  • Application: Clinical decision support, predictive analytics, electronic medical record integration, mobile interfaces, data analytics, remote monitoring, risk stratification, and telehealth are key focus areas for software deployment.
  • End-User: Tailored solutions are delivered to hospitals, clinics, and homecare providers, reflecting unique workflow and compliance requirements for each care setting.
  • Deployment Model: Options include cloud-based, on-premises, and web-based solutions, enabling flexibility to meet diverse regulatory and IT strategies.
  • Regions Covered: The market spans the Americas (including North America and Latin America), Europe, Middle East & Africa, and Asia-Pacific. Each region has its own pace of technology adoption and specific compliance dynamics.

Key Companies Profiled

  • Abbott Laboratories
  • AliveCor, Inc.
  • Astellas Pharma Inc.
  • Axis Clinical Software, Inc.
  • Biofourmis Inc.
  • Biome.io
  • BIOPAC Systems Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardiac RMS, LLC by DocGo, Inc.
  • CitiusTech Inc.
  • Cleerly, Inc.
  • CV Medical Software
  • Dyad Medical Inc.
  • Eko Health Inc.
  • Elucid Bioimaging Inc.
  • Endotronix, Inc
  • Epic Systems Corporation
  • Foundry Innovation & Research 1 Ltd.
  • GE HealthCare Technologies Inc.
  • Heart Input Output Inc.
  • Implicity
  • International Business Machines Corporation
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • N. Harris Computer Corporation
  • NorthEast Monitoring, Inc.
  • Oracle Corporation
  • PaceMate, LLC
  • Pacertool AS
  • Precordior Ltd.
  • Siemens AG
  • Ultromics Limited
  • VectraCor Inc.
  • VUNO Inc.
  • ZOLL Medical Corporation

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Machine learning and analytics enhance heart failure software, facilitating proactive management and supporting evidence-based treatment strategies across care settings.
  • Interoperable solutions compliant with evolving regulations are expanding adoption in both enterprise hospitals and smaller clinics, reducing integration barriers and streamlining workflows.
  • Flexible deployment and licensing options empower vendors and buyers to address distinct IT, regulatory, and financial requirements while supporting ongoing digital transformation efforts.
  • Partnerships and risk-sharing agreements between technology providers and healthcare stakeholders are emerging, promoting alignment towards outcome-based care delivery and reimbursement frameworks.
  • Patient-focused features, such as remote monitoring and mobile interfaces, are strengthening engagement, supporting care transitions, and encouraging adherence for improved long-term outcomes.

Tariff Impact: Regulatory Influences on Cost and Supply Chain

Recent trade tariffs in the United States have contributed to increased costs for imported hardware necessary for heart failure software platforms. In response, providers are pursuing component localization and moving towards cloud-native delivery to reduce dependence on hardware imports. These strategies are helping manage costs, mitigate supply chain disruptions, and allow long-term contracts to emphasize shared risk and outcomes-based incentives.

Methodology & Data Sources

Comprehensive analysis is built on the review of peer-reviewed publications, current regulatory standards, in-depth stakeholder interviews, and benchmarking against industry metrics. The use of frameworks, such as SWOT analysis and value chain mapping, provides a robust foundation for understanding market drivers and risks.

Why This Report Matters for Heart Failure Software Market Leaders

  • Obtain a thorough perspective on how technology advancements, regulatory trends, and competitive developments are shaping adoption across the heart failure software market.
  • Recognize actionable segmentation and deployment patterns to better align investments with patient care priorities and compliance needs in different care environments.
  • Make informed procurement and strategy decisions by understanding the impact of tariffs, evolving delivery models, and the dynamics of risk-sharing partnerships.

Conclusion

The heart failure software market is positioned for continued expansion, influenced by technology innovation and collaborative ecosystem partnerships. Organizations tracking regulatory and operational shifts will secure advantages in care optimization and market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Integration of AI-driven predictive analytics into heart failure management platforms
5.2. Adoption of remote patient monitoring devices with cloud-based data aggregation for heart failure care
5.3. Development of personalized medication adherence tools powered by wearable device insights
5.4. Implementation of telehealth-enabled heart failure clinics with real-time biometric trend analysis
5.5. Utilization of blockchain technology for secure sharing of heart failure patient data across providers
5.6. Expansion of patient engagement apps featuring interactive education modules for self-management support
5.7. Emergence of machine learning algorithms for early detection of decompensation in heart failure patients
5.8. Integration of electronic health record interoperability standards to streamline heart failure workflows
5.9. Deployment of voice-enabled virtual assistants to guide heart failure patients through daily regimen adherence
5.10. Leveraging digital twin simulations for virtual testing of heart failure treatment strategies and outcomes
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Heart Failure Software Market, by Type
8.1. Knowledge Based
8.2. Non-Knowledge Based
9. Heart Failure Software Market, by Disease Type
9.1. Congenital Heart Failure
9.2. Left-Sided Heart Failure
9.3. Right-Sided Heart Failure
10. Heart Failure Software Market, by Platform
10.1. Integrated
10.2. Standalone
11. Heart Failure Software Market, by Application
11.1. Clinical Decision Support
11.2. Data Analytics
11.3. Electronic Medical Record Integration
11.4. Mobile & Patient-centric Applications
11.5. Predictive Analytics & Risk Stratification Tools
11.6. Remote Monitoring & Telehealth Platform
12. Heart Failure Software Market, by End-User
12.1. Clinics
12.2. Homecare Settings
12.3. Hospitals
13. Heart Failure Software Market, by Deployment Model
13.1. Cloud-Based Systems
13.2. On-Premises
13.3. Web-Based
14. Heart Failure Software Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Heart Failure Software Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Heart Failure Software Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. AliveCor, Inc.
17.3.3. Astellas Pharma Inc.
17.3.4. Axis Clinical Software, Inc.
17.3.5. Biofourmis Inc.
17.3.6. Biome.io
17.3.7. BIOPAC Systems Inc.
17.3.8. Boston Scientific Corporation
17.3.9. Canon Medical Systems Corporation
17.3.10. Cardiac RMS, LLC by DocGo, Inc.
17.3.11. CitiusTech Inc.
17.3.12. Cleerly, Inc.
17.3.13. CV Medical Software
17.3.14. Dyad Medical Inc.
17.3.15. Eko Health Inc.
17.3.16. Elucid Bioimaging Inc.
17.3.17. Endotronix, Inc
17.3.18. Epic Systems Corporation
17.3.19. Foundry Innovation & Research 1 Ltd.
17.3.20. GE HealthCare Technologies Inc.
17.3.21. Heart Input Output Inc.
17.3.22. Implicity
17.3.23. International Business Machines Corporation
17.3.24. iRhythm Technologies, Inc.
17.3.25. Koninklijke Philips N.V.
17.3.26. Medtronic PLC
17.3.27. N. Harris Computer Corporation
17.3.28. NorthEast Monitoring, Inc.
17.3.29. Oracle Corporation
17.3.30. PaceMate, LLC
17.3.31. Pacertool AS
17.3.32. Precordior Ltd.
17.3.33. Siemens AG
17.3.34. Ultromics Limited
17.3.35. VectraCor Inc.
17.3.36. VUNO Inc.
17.3.37. ZOLL Medical Corporation
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Heart Failure Software market report include:
  • Abbott Laboratories
  • AliveCor, Inc.
  • Astellas Pharma Inc.
  • Axis Clinical Software, Inc.
  • Biofourmis Inc.
  • Biome.io
  • BIOPAC Systems Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Cardiac RMS, LLC by DocGo, Inc.
  • CitiusTech Inc.
  • Cleerly, Inc.
  • CV Medical Software
  • Dyad Medical Inc.
  • Eko Health Inc.
  • Elucid Bioimaging Inc.
  • Endotronix, Inc
  • Epic Systems Corporation
  • Foundry Innovation & Research 1 Ltd.
  • GE HealthCare Technologies Inc.
  • Heart Input Output Inc.
  • Implicity
  • International Business Machines Corporation
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • N. Harris Computer Corporation
  • NorthEast Monitoring, Inc.
  • Oracle Corporation
  • PaceMate, LLC
  • Pacertool AS
  • Precordior Ltd.
  • Siemens AG
  • Ultromics Limited
  • VectraCor Inc.
  • VUNO Inc.
  • ZOLL Medical Corporation

Table Information